SUBCLASSIFICATION OF CLASS-I ANTIARRHYTHMIC DRUGS - ENHANCED RELEVANCE AFTER CAST

被引:18
作者
CAMPBELL, TJ [1 ]
机构
[1] ST VINCENTS HOSP,DEPT CARDIOL,DARLINGHURST,NSW 2010,AUSTRALIA
关键词
ANTIARRHYTHMIC DRUGS; PROARRHYTHMIA; QUINIDINE; FLECAINIDE; ENCAINIDE;
D O I
10.1007/BF00055611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Class I antiarrhythmic drugs are traditionally divided into three subclasses-Ia, Ib, and Ic-on the grounds of differences in kinetics of interaction with the sodium channel and different effects on the duration of the action potential. The CAST study has highlighted our growing awareness of the proarrhythmic potential of this group of agents, particularly the Class Ic subgroup. Class I drugs can cause arrhythmias either by slowing conduction to critical levels, thus enhancing the possibility of reentrant arrhythmias, or in some cases by prolonging action potential duration, leading to early afterdepolarizations, which probably underlie triggered automaticity. Evidence is presented that the Class Ic compounds may be inherently more proarrhythmic than the Ib compounds, because of their lesser ability to depress ischemic myocardium selectively. Arguments are advanced for the continued use of a slightly modified subclassification of Class I antiarrhythmic drugs.
引用
收藏
页码:519 / 528
页数:10
相关论文
共 60 条
[11]  
CAMPBELL TJ, 1991, J CARDIOVASC PHARM, V18, P514
[12]  
Cobbe SM., 1989, ANTIARRHYTHMIC DRUGS, P365
[13]   CHANNEL SPECIFICITY IN ANTIARRHYTHMIC DRUG-ACTION - MECHANISM OF POTASSIUM CHANNEL BLOCK AND ITS ROLE IN SUPPRESSING AND AGGRAVATING CARDIAC-ARRHYTHMIAS [J].
COLATSKY, TJ ;
FOLLMER, CH ;
STARMER, CF .
CIRCULATION, 1990, 82 (06) :2235-2242
[14]  
COOPER MJ, 1991, AUST NZ J MED, V21, P546
[15]   EFFICACY AND SAFETY OF QUINIDINE THERAPY FOR MAINTENANCE OF SINUS RHYTHM AFTER CARDIOVERSION - A METAANALYSIS OF RANDOMIZED CONTROL TRIALS [J].
COPLEN, SE ;
ANTMAN, EM ;
BERLIN, JA ;
HEWITT, P ;
CHALMERS, TC .
CIRCULATION, 1990, 82 (04) :1106-1116
[16]   USE-DEPENDENT EFFECTS OF LIDOCAINE ON CONDUCTION IN CANINE MYOCARDIUM - APPLICATION OF THE MODULATED RECEPTOR HYPOTHESIS INVIVO [J].
DAVIS, J ;
MATSUBARA, T ;
SCHEINMAN, MM ;
KATZUNG, B ;
HONDEGHEM, LH .
CIRCULATION, 1986, 74 (01) :205-214
[17]   LIDOCAINE CAUSES A REVERSIBLE, CONCENTRATION-DEPENDENT INCREASE IN DEFIBRILLATION ENERGY-REQUIREMENTS [J].
DORIAN, P ;
FAIN, ES ;
DAVY, JM ;
WINKLE, RA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (02) :327-332
[18]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788
[19]   EVALUATION OF ANTIARRHYTHMIC DRUGS ON DEFIBRILLATION ENERGY-REQUIREMENTS IN DOGS - SODIUM-CHANNEL BLOCK AND ACTION-POTENTIAL PROLONGATION [J].
ECHT, DS ;
BLACK, JN ;
BARBEY, JT ;
COXE, DR ;
CATO, E .
CIRCULATION, 1989, 79 (05) :1106-1117
[20]   THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL - 1ST CAST ... THEN CAST-II [J].
GREENE, HL ;
RODEN, DM ;
KATZ, RJ ;
WOOSLEY, RL ;
SALERNO, DM ;
HENTHORN, RW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (05) :894-898